9 resultados
TECHNICAL FIELD
The present invention relates to methods and products for providing oral nutritional care to subjects with dementia.
BACKGROUND OF THE INVENTION
Dementia is a group of disorders characterized by loss of integrated central nervous system functions, resulting in a diminished ability to
TECHNICAL FIELD
The present invention relates to methods and products for providing oral nutritional care to subjects with dementia.
BACKGROUND OF THE INVENTION
Dementia is a group of disorders characterized by loss of integrated central nervous system functions, resulting in a diminished ability to
TECHNICAL FIELD
The present invention relates to methods and products for providing oral nutritional care to subjects with dementia.
BACKGROUND OF THE INVENTION
Dementia is a group of disorders characterized by loss of integrated central nervous system functions, resulting in a diminished ability to
FIELD OF THE INVENTION
This invention relates to the field of therapeutic agents for the treatment of Alzheimer's Disease, and other diseases associated with reduced neuronal metabolism.
BACKGROUND OF THE INVENTION
Alzheimer's Disease (AD) is a progressive neurodegenerative disorder, which primarily
FIELD OF THE INVENTION
This invention relates to the field of therapeutic agents for the treatment of Alzheimer's Disease, and other diseases associated with reduced neuronal metabolism, including Parkinson's disease, Huntington's Disease, and epilepsy.
BACKGROUND OF THE INVENTION
Alzheimer's
FIELD OF THE INVENTION
This invention relates to the field of therapeutic agents for the treatment of Alzheimer's Disease, and other diseases associated with reduced neuronal metabolism, including Parkinson's disease, Huntington's Disease, and epilepsy.
BACKGROUND OF THE INVENTION
Alzheimer's
FIELD OF THE INVENTION
This invention relates to the field of therapeutic agents for the treatment of Alzheimer's Disease, and other diseases associated with reduced neuronal metabolism, including Parkinson's disease, Huntington's Disease, and epilepsy.
BACKGROUND OF THE INVENTION
Alzheimer's
FIELD OF THE INVENTION
This invention relates to the field of therapeutic agents for the treatment of Alzheimer's Disease, and other diseases associated with reduced neuronal metabolism, including Parkinson's disease, Huntington's Disease, and epilepsy.
BACKGROUND OF THE INVENTION
Alzheimer's
TECHNICAL FIELD
The present invention relates to a pharmaceutical composition for treating or preventing a neurodegenerative disease comprising an RXR agonist as an active ingredient.
BACKGROUND ART
There have been studies on a strategy for treating neurodegenerative diseases, in particular dementia